Apellis Pharmaceuticals APLS 深 沪
等待开盘 09-20 09:30:00 美东时间
36.73
+1.100
+3.09%
华盛通- 最 高37.835
- 今 开36.24
- 成交量 176.01万股
- 最 低 36.10
- 昨 收 35.63
- 总市值 44.44亿
- 52周最高 73.80
- 市盈率 静 --
- 换手率 1.45%
- 52周最低 33.49
- 委 比 -30.79%
- 总股本 1.21亿
- 历史最高 94.75
- 量 比 1.23
- 振 幅 4.87%
- 历史最低 11.45
- 每 手 1
- 风险率 10.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多快讯 | Apellis在欧盟地理性萎缩（GA）方面的Pegcetacoplan获得了CHMP的否定意见，在复审后。
Apellis Receives Negative Chmp Opinion for Pegcetacoplan for Geographic Atrophy...
今天 17:00
Apellis Pharmaceuticals (APLS) Gets a Hold from Mizuho Securities
Mizuho Securities analyst Graig Suvannavejh maintained a Hold rating on Apellis...
09-16 14:25
Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals
Across the recent three months, 15 analysts have shared their insights on Apell...
09-14 05:01
快讯 | Apellis Pharmaceuticals Inc：瑞穗将目标价从42美元下调至39美元
Apellis Pharmaceuticals Inc : Mizuho Cuts Target Price to $39 From $42
09-13 18:40
Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) Profit Outlook
We feel now is a pretty good time to analyse Apellis Pharmaceuticals, Inc.'s (N...
08-23 21:33
快讯 | Apellis制药公司：摩根大通将目标价从72美元下调至64美元
Apellis Pharmaceuticals Inc : JP Morgan Cuts Target Price to $64 From $72
08-13 10:58
快讯 | Apellis药品公司：瑞银将目标价从85美元下调至83美元
Apellis Pharmaceuticals Inc : UBS Cuts Target Price to $83 From $85
08-09 22:13
快讯 | Apellis制药公司：Jefferies将目标价从80美元上调至82美元
Apellis Pharmaceuticals Inc : Jefferies Raises Target Price to $82 From $80
08-09 16:48
快讯 | Apellis Pharmaceuticals股份有限公司：Baird将目标价从86美元上调至96美元。
Apellis Pharmaceuticals Inc : Baird Raises Target Price to $96 From $86
08-08 23:21
Apellis stock jumps as rare kidney disease therapy succeeds in trial
Apellis Pharmaceuticals (NASDAQ:APLS) and partner Sobi’s experimental rare kidney disease therapy pegcetacoplan has met the primary endpoint in a Phase 3 trial. The VALIANT trial is evaluating pegceta...
08-08 19:54
